GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medite Cancer Diagnostics MDIT · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2017

Revenue

$6.8m

FY2014FY2017

Net income

−$6.8m

FY2014FY2017

Free cash flow

−$2.7m

FY2014FY2017

Shareholders' equity

$5.8m

FY2014FY2017

Income statement

Fiscal years

FY2017FY2016FY2015FY2014
Revenue$6.8m$9.2m$9.9m$11.0m
Gross profit−$131,000$3.4m$3.6m$3.8m
Research and development$1.2m$1.5m$1.3m$1.2m
Operating income−$6.5m−$1.7m−$599,000−$394,000
Net income−$6.8m−$2.2m−$859,000−$699,000
Diluted earnings per share-0.23-0.09-0.42-0.02

Balance sheet

At each fiscal year end

FY2017FY2016FY2015FY2014
Total assets$16.0m$17.5m$18.4m$18.6m
Cash and short-term investments$490,000$108,000$587,000—
Total liabilities$10.2m$9.5m$9.2m$10.2m
Debt$5.4m$4.1m$4.0m$3.8m
Shareholders' equity$5.8m$8.0m$9.2m$8.4m
Shares outstanding29m24m2m41m

Cash flow

Fiscal years

FY2017FY2016FY2015FY2014
Cash from operations−$2.6m−$1.1m−$388,000−$891,000
Capital spending−$134,000−$115,000−$354,000−$463,000
Free cash flow−$2.7m−$1.2m−$742,000−$1.4m

Latest quarters

By quarter end

Sept 2018Jun 2018Mar 2018Dec 2017Sept 2017Jun 2017Mar 2017Dec 2016
Revenue$2.4m$2.3m$1.5m$2.0m$1.7m$1.3m$1.9m$2.0m
Gross profit$1.5m$1.1m$335,000−$936,000$369,000$49,000$680,000$439,000
Operating income−$95,000−$28,000−$960,000−$3.0m−$1.4m−$1.4m−$576,000−$977,000
Net income−$735,000−$563,000−$1.4m−$2.6m−$1.6m−$1.6m−$955,000−$1.0m
Diluted earnings per share-0.01-0.01-0.02-0.09-0.06-0.06-0.03-0.04
Cash from operations—−$1.0m−$1.0m−$1.0m————
Total assets$17.7m$16.6m$16.4m$16.0m$19.0m$18.1m$17.8m$17.8m
Debt$6.1m$5.8m$5.6m$5.3m$4.9m$3.8m$3.4m$3.6m
Shareholders' equity$5.5m$5.1m$5.0m$4.8m$8.0m$8.3m$8.6m$8.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-14.7%102.9%56.0%
Operating income154.3%28.9%-2.2%
Net income113.6%30.8%-1.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin20.5%29.1%40.5%40.6%
Operating margin-50.7%-24.7%-28.7%-89.2%
Net margin-55.9%-28.5%-33.0%-96.0%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-98%4900%-99%9800%-65%23310%10346%11169%37%142%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 12 Mar 2015
  • 10-to-1 reverse split · 28 Nov 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.